James M. Hindman
Independent DirectorMr. James M. Hindman, also known as Jim, is a Director of Aatru Medical, LLC. He is Director at Amolyt Pharma SAS since 2021. He has been a Director of NeuroSigma, Inc. since February 2014 and an Independent Director of Millendo Therapeutics, Inc. since June 23, 2016. Mr. Hindman served as a Director of Urovant Sciences Ltd. since May 20, 2020 until March 29, 2021. He serves as Independent Director of Accuray Incorporated since September 6, 2019. He serves as Director of Aatru Medical. He is experienced healthcare executive and worked at Allergan, Inc., is an accomplished financial executive with expertise in maximizing shareholder value. He served as the Chief Financial Officer and Executive Vice President of Finance & Business Development at Allergan Inc. since August 18, 2014 until March 2015. Mr. Hindman has experience leading and working with diverse global businesses in the pharmaceutical, biologics and medical device industries. Mr. Hindman served as the Chief Financial Officer of Allergan Specialty Therapeutics Inc. since April 2000. Mr. Hindman served as Senior Vice President of Investor Relations, Treasury and Risk at Allergan Inc. since March 2002 until August 2014. He served as the Director of Manufacturing Planning and Reporting and Senior Vice President of Investor Relations at Allergan Inc. He served as Vice President of Financial Planning & Analysis at Allergan Specialty Therapeutics, Inc., since February 1997. From 2000 to 2002, Mr. Hindman served as Senior Vice President Finance and Controller at Allergan. Mr. Hindman first joined Allergan in 1984. He served years in a variety of positions at Allergan, including Plant Controller, Director of Manufacturing Planning and Reporting, Director of Finance (Northwest Europe) and Assistant Corporate Controller. Mr. Hindman worked at Deloitte, Haskins and Sells. He is a member of the Loyola Marymount University Board of Regents. Since December 2017, Mr. Hindman has provided financial consulting services to RANI Therapeutics. Since July 2015, Mr. Hindman has also provided financial consulting services to Cidara Therapeutics Inc. He had been Director of Sienna Biopharmaceuticals, Inc. since August 2, 2018. Mr. Hindman was President of The Allergan Foundation from October 2009 to December 2015 and has served as a Member of the Loyola Marymount Accounting Advisory Board since 2007 until June 2015. He has a Bachelor Science degree in Accounting from Loyola Marymount University, an MBA from Pepperdine University and is a Certified Public Accountant (inactive).
Positions
- Company NameAccuray IncorporatedStock CodeARAYPositionIndependent DirectorColleagues
- SRStephen R. LaNevePresident, CEO & Director
- JEJoseph E. WhittersIndependent Chairman of the Board
- APAli PervaizSenior VP & CFO
- PMPaul MieleSenior VP & Chief Commercial Officer
- MJMichael J. MurphyCorporate Controller & Principal Accounting Officer
- DSDavid ShinSenior VP, Chief Legal Officer & Corporate Secretary
- MNMika NishimuraIndependent Director
- SFSteven Francis MayerDirector
